Health

More news - Recent news Rwanda has reported an outbreak of Marburg virus, a severe hemorrhagic fever known for its high mortality rate, with 11 fatalities this year. This marks the first appearance of the virus in Rwanda, located in east-central Africa, despite its presence in several other African nations in recent decades. Rwanda's Health Ministry has identified 36 cases since the virus was first detected in late September. In a related development, German health authorities have confirmed that two people suspected of having the Marburg virus have tested negative. The scare led to temporary restrictions at a major Hamburg train station, following symptoms the couple showed after one of them had contact with an infected individual in Rwanda. The authorities have reass...

Related media - Breaking news Rwanda is currently battling an epidemic of Marburg virus disease, a rare but serious hemorrhagic fever. Since the end of September, 36 cases and 11 deaths have been reported. Although caused by different viruses, Marburg shares similarities with Ebola in transmission, symptoms and progression. The virus is initially transmitted from fruit bats to humans. Previous outbreaks have occurred in Africa, but not in Rwanda. A medical student in Germany who had contact with an infected patient in Rwanda has shown symptoms. Tests confirmed negative for Marburg, reassuring the public that there is no current risk. First identified in 1967, Marburg virus can cause severe bleeding and organ failure. The World Health Organization (WHO) provides resourc...

More news - Recent news A pharmaceutical company's attempt to win approval for a new Alzheimer's treatment, simufilam, continues amid a flurry of controversy and regulatory challenges. Recent investigations have cast doubt on the basic studies supporting simufilam. These concerns increased when scientific journals retracted several studies and key figures at Cassava Sciences, the drug's sponsor, resigned. Despite these setbacks, in September the Securities and Exchange Commission (SEC) accused Cassava Sciences of disseminating misleading data about their clinical trials. However, the company settled these charges by paying $40 million, without admitting any guilt. Interestingly, simufilam is still undergoing Phase 3 trials, involving more than 1,900 participants, as the last...

More news - News 24 hours In an effort to mitigate potential backlash in the upcoming presidential election, the Biden administration announced a significant reduction in Medicare drug premiums for 2025, achieved by allocating billions in subsidies to insurers. This strategic decision aims to prevent increased costs for older Americans, who represent a crucial voter base. The administration used funds from the Medicare fund to subsidize insurance companies, preventing what could have been a sharp increase in premiums due to the $2,000 annual cap on out-of-pocket expenses introduced by President Biden's Inflation Reduction Act. Without this government intervention, older individuals could have faced an annual increase of hundreds of dollars. This maneuver is seen by some ...

Related media - Breaking news “Life After Love” explores the poignant journey of finding companionship after a significant loss. This narrative reveals the transformative experience of dating as an elderly widow. Four months after losing her spouse after three decades of marriage, Kathryn Shephard Cowan ventured back into the dating scene with a visit to the symphony orchestra with a seemingly agreeable gentleman. Despite her initial determination, Kathryn found herself unexpectedly overwhelmed by the music of Beethoven, her late husband's favorite composer, leaving her unable to connect with her date. This story, written by Catherine Pearson, a journalist renowned for her insights into family and relationships, delves into the emotional layers and complexities tha...

More news - Recent news The global fight against infectious diseases is undergoing a fundamental shift in perspective. For years, the dominant narrative around antimicrobial resistance (AMR) has focused on the overuse of antibiotics, painting a picture of a world grappling with increasingly ineffective drugs. While the dangers of overprescribing remain real, a growing chorus of experts argue that this focus overlooks a more fundamental issue: Millions of people don't have access to even the most basic antibiotics. At a recent United Nations meeting, health leaders highlighted this overlooked aspect of antimicrobial resistance. The inability of poor families to afford a simple course of antibiotics, resulting in preventable deaths, highlights a tragic disparity. Experts s...